Trial
NCT05322850
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Orca Biosystems, Inc.; Florida Department of Health
Condition
Acute Myeloid Leukemia
Intervention
Orca-Q
Why stopped
Seeking additional funding sources
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13